Genentech, Inc. (Genentech) is a biotechnology company that discovers, develops, manufactures and commercializes pharmaceutical products to treat patients with unmet medical needs. It commercializes multiple biotechnology products and also receives royalties from companies that are... more

Millipore Corporation (Millipore) is a life science company that provides products, services and solutions. The Company’s academic, biotechnology, and pharmaceutical customers use its consumable products and services in laboratory applications and in biopharmaceutical manufacturing.... more

Cambrex Corporation is a life sciences company engaged primarily in the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. Products and services are supplied globally to generic drug companies. Cambrex primarily supplies its products and... more

CuraGen Corporation (CuraGen) is a biopharmaceutical development company engaged in developing therapeutics for the treatment of cancer. The Company is focused on advancing its cancer treatments, belinostat and CR011-vcMMAE, through clinical development and toward commercialization. In... more

Alfacell Corporation is a biopharmaceutical company engaged in the discovery and development of a class of therapeutic drugs for the treatment of cancer and other pathological conditions. The Company’s drug discovery and development program consists of therapeutics, which are being... more

Morphotek(R), Inc., a subsidiary of Eisai Co., Ltd., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology. The technology has been successfully applied to a broad variety of... more

XOMA Ltd. is a biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies. The Company’s lead product candidate is XOMA 052, a high affinity anti-IL-1 beta antibody with the potential to treat multiple inflammatory diseases of large unmet... more

CV Therapeutics, Inc. is a biopharmaceutical company focused primarily on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases. The Company applies advances in molecular biology and genetics to identify mechanisms of... more

Zymogenetics, Inc. is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases. The Company's therapeutic focus is in the areas of hemostasis, inflammatory and autoimmune diseases, cancer and viral infections. Its... more

About Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Eyetech's initial focus is on diseases affecting the back of the eye. Eyetech is... more

Dyax Corp. (Dyax) is a clinical stage biotechnology company focused on the discovery, development and commercialization of biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications. Dyax uses the drug discovery technology, known as phage display,... more

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, co- promotes INTEGRILIN® (eptifibatide) Injection, a market-leading cardiovascular product, and has a robust clinical development pipeline of product... more

CRT aims to maximise the potential benefit to cancer patients flowing from publicly-funded cancer research worldwide, and in so doing, be recognized as the leading oncology-focused technology transfer and development company. CRT achieves its aim by: Identifying and protecting new... more

Tanox is a growing biotechnology company with great career opportunities. We are headquartered in Houston, Texas near the world-renowned Texas Medical Center. We also maintain a manufacturing facility in San Diego, California.

Microbix Biosystems Inc. is a Canada-based company. The Company is engaged in the development, manufacturing and distribution of cell-based products and technology and, provision of facility, technical and production personnel for contract research and development. Sequent Biotechnologies... more

Acceleron is establishing itself as the premier company in GDF-targeted therapies. We have developed an unparalleled expertise in GDF biology, and our scientific advisory board consists of leaders and pioneers in the field. Our discoveries and technology have allowed us to unleash the... more

ThromboGenics is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system.

Dyadic International, Inc. (Dyadic) is a global biotechnology company that uses its technologies (the Dyadic Platform Technology) to conduct research and development activities for the discovery, development, and manufacture of products and enabling solutions to the bioenergy, industrial... more

PharmAthene, Inc. (PharmAthene), formerly Healthcare Acquisition Corp., is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons. The Company has two products under development: Valortim, a fully human... more

BioSyntech, Inc. is a canada-based company that develops biotherapeutic thermogels specifically designed for tissue repair and delivery of therapeutic agents. The Company is developing a first line of products for cartilage repair, chronic wound healing and plantar pain relief, which have... more

ProMetic Life Sciences Inc. is a global biopharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics, clinical diagnostics, and the elimination of pathogens. The Company is developing products to treat anemia, neutropenia, cancer and... more

Emergent BioSolutions Inc. (Emergent) is a multinational biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics, consisting of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. It manufactures and... more

Onyx Pharmaceuticals, Inc. (Onyx) is a biopharmaceutical company engaged in developing therapies that target the molecular mechanisms that cause cancer. With the Company’s collaborators, the Company is developing small molecule drugs. The Company develops oral anticancer therapies... more

Avidia is a privately-held biopharmaceutical company discovering, developing and manufacturing a new class of human therapeutic proteins known as Avimerâ„¢ Proteins. We are engineering these Avimer Protein drugs against multiple validated and novel targets to address a wide range of... more

DNA Diagnostics Center (http://www.dnacenter.com) is the world's largest provider of private paternity tests. Since 1995, DDC has performed hundreds of thousands of genetic tests for clients around the world. DDC offers comprehensive DNA testing services in several specialty areas: family... more

Talecris Biotherapeutics Holdings Corp. is a biopharmaceutical company that is a producer and marketer of plasma-derived protein therapies in the world. The Company develops, produces, markets and distributes therapies that help people suffering from conditions, such as immune deficiency... more

Northwest Biotherapeutics, Inc. is a development-stage biotechnology company focused on discovering, developing, and commercializing immunotherapy products that generate and enhance immune system responses to effectively treat cancer. The Company's approach in developing cancer therapies... more

At Corvas International Inc., we are dedicated to developing breakthrough medicines with the potential to profoundly improve the lives of millions of people living with cardiovascular disease and cancer. Our commitment is to bring to the market a new generation of biotherapeutics with... more

Xencor's employees are the most important factor in our success. We have assembled a highly talented group from diverse backgrounds and disciplines to execute our business plan and shape our future. Xencor employees value new ideas and flexibility and demand from each other scientific... more

Spherics, Inc. is focused on developing innovative and proprietary pharmaceutical products to address the significant unmet clinical needs of neurological disorders. Our mission is to develop and commercialize neurological treatments to overcome the limitations of existing therapies... more

NaPro BioTherapeutics, Inc. (NASDAQ:NPRO) is a life science company focused in two distinct areas: the development and in-licensing of anti-cancer agents and the development of genomic therapies, employing our proprietary gene editing technology.

Biotest AG, Dreieich is a pharmaceutical and diagnostics company with approximately 1,000 employees world-wide. Biotest is specialized in the development, production and marketing of therapeutic and diagnostic systems with a focus on clinical immunology, autoimmune disease, haematology... more

U3 Pharma AG is an emerging leader in targeted cancer drug development. The company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Prof. Axel Ullrich. U3 Pharma´s vision is to provide clinical oncologists with an... more

GlycoFi is a rapidly growing biotechnology company with facilities located in Lebanon, NH. GlycoFi's innovative research program is radically changing the development and production of protein-based therapeutics. We are seeking highly motivated individuals to join our team. The successful... more

CardioVascular BioTherapeutics, Inc. (Cardio) is a development-stage biopharmaceutical company focused on developing drugs to stimulate the growth of new blood vessels for the treatment of cardiovascular diseases. The active pharmaceutical ingredient (API) in the Company’s drug candidates... more

Neuralstem, Inc. is a biotechnology company focused on developing and commercializing human neural stem cell technology in the field of regenerative medicine. The Company manufactures its cells both in-house and on an outsource basis. It uses these cells in its research grant and... more

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium research, development and commercialization activities are... more

BHARAT Biotech International, a leading biotech player, has entered into a manufacturing and marketing agreement with British company Acambis Plc to develop and commercialise ChimeriVax-JE, a vaccine used for the treatment of Japanese Encephalitis. Acambis develops vaccines for the... more

Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system. Using its ProCellEx system, the Company is developing a pipeline of recombinant therapeutic... more

Protiva is a development stage biotechnology company, focused on pharmaceutical products to fight serious human disease. Protiva's proprietary SNALP technology enables the development of novel nucleic acid-based drugs, such as those that utilize siRNA. Protiva was founded in September... more

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME's principal focus has been on applying its proprietary AMEsystemÔ technology platform to... more

Anthrogenesis is a fully integrated biotechnology company focused on human stem cell therapeutics and regenerative medicine. Through an array of biomedical services, research and development, Anthrogenesis is helping expand the clinical and scientific frontiers in the application of human... more

Aerovance is a biopharmaceutical company focused on the development and commercialization of clinical-stage products for respiratory and allergic diseases. The company's goal is to build an integrated company, with acknowledged expertise in leveraging operational partnerships that include... more

Ellipsis Biotherapeutics Corporation is a privately held drug and diagnostic discovery company developing novel medicines for human diseases where existing therapies are unable to address patient needs. The company's lead programs are in Alzheimer's Disease and Inflammatory Bowel Disease,... more

Intrexon Corporation is a privately-held life sciences company headquartered at the Virginia Tech Corporate Research Center in Blacksburg, Virginia, with additional R&D operations in Valley Forge, Pennsylvania. The company is focused on the research and development of transcriptional... more

Receptor BioLogix, Inc. is a biopharmaceutical company focused on the discovery and development of proprietary biotherapeutics designed to modulate the receptor tyrosine kinase (RTK) family of cell-surface receptors. These receptors are involved in most cancers and many other diseases.

GenOdyssee is a drug discovery company using a unique, IP-protected approach to discovery of superior protein products. GenOdyssee discovers natural variants of proteins with higher efficacy and safety than marketed versions of the same therapeutic proteins. This approach is ideal for... more

ConjuGon was founded in 2001 by University of Wisconsin-Madison professors Marcin Filutowicz and Richard Burgess to develop products to combat the growing epidemic of antibiotic resistance. Today, the company has a dedicated team working on products to prevent and treat bacterial... more

Genzyme Biosurgery is a leading developer of novel biotherapeutic and biomaterial products used to treat serious diseases. Its products and pipeline are concentrated in the rapidly growing markets of orthopaedics and heart disease and in broader surgical applications.

CovX was founded in 2002 based on the research of Carlos Barbas, Ph.D. and Richard Lerner, M.D. at The Scripps Research Institute. Since its founding, CovX has made advances toward building a portfolio of product candidates. We use our proprietary technology to rapidly discover and... more